Keywords: Brazil, Mexico, Type 2 diabetes, Government funding, DPP-IV inhibitors, Decision Resources

Lack of government funding in Brazil and Mexico holds back use off DPP-IV diabetes drugs

Article | 19 July 2012

The majority of type 2 diabetes patients in Brazil and Mexico rely heavily or entirely on government-sponsored medical programs to cover ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in